Fig. 1From: Using four decades of FDA orphan drug designations to describe trends in rare disease drug development: substantial growth seen in development of drugs for rare oncologic, neurologic, and pediatric-onset diseasesCount of FDA orphan drug designations by decade, 1983—2019. 1980s includes 1983–1989Back to article page